Portions of this manuscript have been presented in poster format at the Eating Disorders Research Society Meeting, Brooklyn New York, 2009.
A prevalence study and Description of alli® use by patients with eating disorders†
Article first published online: 7 MAY 2010
Copyright © 2010 Wiley Periodicals, Inc.
International Journal of Eating Disorders
Volume 43, Issue 5, pages 472–479, July 2010
How to Cite
Steffen, K. J., Mitchell, J. E., le Grange, D., Crow, S. J., Attia, E., Bulik, C. M., Dellava, J. E., Bermudez, O., Erickson, A. L., Crosby, R. D. and Bansal-Dev, V. P. (2010), A prevalence study and Description of alli® use by patients with eating disorders. Int. J. Eat. Disord., 43: 472–479. doi: 10.1002/eat.20829
- Issue published online: 1 JUN 2010
- Article first published online: 7 MAY 2010
- Manuscript Accepted: 4 MAR 2010
- eating disorders;
- anorexia nervosa;
- bulimia nervosa;
- binge eating disorder;
- diet pill;
- compensatory method
This study examined the frequency and characteristics of alli® use among patients in eating disorder treatment facilities.
Patients from five treatment centers completed the Survey of Eating and Related Behaviors. Diagnoses were determined from survey responses.
Of 417 survey respondents, 26 (6.2%) reported a history of alli® use. Of those, 15 (57.7%) met criteria for an eating disorder, including one of 29 patients (3.4%) with anorexia nervosa binge-purge subtype, six of 66 patients (9.1%) with full or subthreshold bulimia nervosa, four of 49 (8.2%) with binge eating disorder, one of six (16.7%) with purging disorder, and three of 80 (3.8%) with an eating disorder not otherwise specified.
The results of this survey suggest that patients with eating disorders use alli®, albeit relatively uncommonly. Therefore, it is worthwhile for clinicians to inquire about alli® use when evaluating or treating these patients in any clinical setting. © 2010 by Wiley Periodicals, Inc. Int J Eat Disord 2010